Leap Therapeutics Inc. (NASDAQ: LPTX) flaunted slowness of -11.69% at $2.04, as the Stock market unbolted on March 04, 2021. During the day, the stock rose to $2.31 and sunk to $1.80 before settling in for the price of $2.31 at the close. Taking a more long-term approach, LPTX posted a 52-week range of $1.15-$3.24.
Meanwhile, its Annual Earning per share during the time was -12.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.00%. This publicly-traded company’s shares outstanding now amounts to $76.32 million, simultaneously with a float of $44.00 million. The organization now has a market capitalization sitting at $128.52 million. At the time of writing, stock’s 50-day Moving Average stood at $2.43, while the 200-day Moving Average is $2.09.
Leap Therapeutics Inc. (LPTX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Leap Therapeutics Inc. industry. Leap Therapeutics Inc.’s current insider ownership accounts for 12.04%, in contrast to 54.00% institutional ownership. According to the most recent insider trade that took place on Jun 22, this organization’s 10% Owner bought 1,750,000 shares at the rate of 2.00, making the entire transaction reach 3,500,000 in total value, affecting insider ownership by 8,476,496.
Leap Therapeutics Inc. (LPTX) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.09 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.13) by $0.04. This company achieved a return on equity of -886.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
Leap Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 10.00% and is forecasted to reach -0.42 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -2.49% through the next 5 years, which can be compared against the -12.40% growth it accomplished over the previous five years trading on the market.
Leap Therapeutics Inc. (NASDAQ: LPTX) Trading Performance Indicators
Let’s observe the current performance indicators for Leap Therapeutics Inc. (LPTX). It’s Quick Ratio in the last reported quarter now stands at 8.70. The Stock has managed to achieve an average true range (ATR) of 0.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 116.84.
In the same vein, LPTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.09, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Leap Therapeutics Inc. (LPTX)
Now, what If we examine the latest scores posted by [Leap Therapeutics Inc., LPTX]. During the last 5-days, its volume was lower the volume of 0.87 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 17.81% While, its Average True Range was 0.26.
Raw Stochastic average of Leap Therapeutics Inc. (LPTX) in the period of the previous 100 days is set at 33.70%, which indicates a major rise in contrast to 18.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 78.56% that was lower than 95.30% volatility it exhibited in the past 100-days period.